The NHS must adapt to the changing health landscape and put prevention at its heart if it is to overcome current and future pressures, Public Health England (PHE) said as it published its new Health Profile for England report.

Dubbed as “the most comprehensive picture of the health of England today and into the future”, the report covers life expectancy, major causes of death, mortality trends, child health, inequality in health, wider determinants of health and current health protection issues.

Some of the most notable findings include:

  • The number of people aged 85 years has more than tripled since the 1970s and will include more than two million people by 2031
  • The death rate for dementia and Alzheimer’s disease – already the leading cause of death in women – may overtake heart disease as the leading cause of death in men as early as 2020
  • The number of people with diabetes is expected to increase by a million – from just under four million people in 2017 to almost five million in 2035
  • In the last seven years, smoking prevalence has dropped by a quarter to 15 per cent and as little as 10 per cent of the population could still be smoking by 2023.

It is hoped that the report’s information on future trends in health will aid policy makers, both national and local, to prioritise efforts to prevent ill-health rather than just dealing with the consequences.

The report also highlights that while life expectancy in England has reached 79.6 years for men and 83.2 for women, with every age group being healthier than ever before, stubborn inequalities persist. For example, in the richest areas people enjoy 19 more years in good health than those in the poorest areas.

Duncan Selbie, chief executive at PHE, said: “Inequalities in health undermine not only the health of the people but also our economy. As we work to develop the NHS long term plan, we must set the ambition high. If done right, with prevention as its centrepiece, the payoff of a healthier society and more sustainable NHS will be huge.”

Originally Published by Training Matters

Recommended

Fluad manufacturer: We are on track to meet delivery plan

Seqirus told Pharmacy Magazine that despite “processing challenges” it is on track to meet its delivery sche...

RPS welcomes Avastin AMD ruling

The RPS welcomed the news that the NHS will be able to prescribe Avastin for age-related macular degeneration after winn...




This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.